| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2579161 | Thérapie | 2011 | 8 Pages |
Abstract
Several studies evaluated interest of biomarkers in RA patients treated with biologics: 1- to optimize doses and frequency of drug administration; 2- to predict response to treatment; 3- to predict tolerance of biologics; 4- to monitor patient who stopped treatment and are in remission, and predict new RA flare.
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacology, Toxicology and Pharmaceutics (General)
Authors
Sylvie Fabre,